World Health Organization & Serum Institute of India

World Health Organization: The World Health Organization has declared the Ebola outbreak a 'public health emergency' and is accelerating the assessment process for the vaccine candidate, playing a crucial role in coordinating the global response.

Serum Institute of India: The Serum Institute of India is fast-tracking the development and production of a vaccine candidate for the Bundibugyo strain of Ebola, positioning itself as a key player in global health security and potentially increasing its market value and reputation.

World Health Organization: The World Health Organization (WHO) has declared the outbreak a public health emergency and is involved in monitoring cases and coordinating the global health response.

Serum Institute of India: The Serum Institute of India is manufacturing a vaccine candidate developed by the University of Oxford, receiving up to $8.6 million from CEPI for its development.

World Health Organization: The World Health Organization>>> has declared the Ebola outbreak a public health emergency of international concern and is coordinating the international response, providing experts, supplies, and guidance, though it faces criticism for delayed detection and underestimation of the outbreak's scale.

Serum Institute of India: The Serum Institute of India is manufacturing doses of a vaccine candidate built on the University of Oxford/AstraZeneca platform, which could be used for clinical trials against the Bundibugyo ebolavirus.